Table 3.2:
MOS SF-36 Group Means for LGG by Age at Interview
| MOS SF-36 Health Domain | 20–29 (n = 29) | 30–39 (n = 81) | 40–49 (n = 74) | 50–59 (n = 63) | 60–69 (n = 27) | 70+ (n = 4) | P-Value |
|---|---|---|---|---|---|---|---|
| Physical Functioning | 87.76 | 87.32 | 84.66 | 79.44 | 80.04 | 83.75 | p = 0.31 |
|
| |||||||
| Role-Physical | 51.72 | 50.62 | 59.46 | 52.42 | 55.56 | 56.25 | p = 0.87 |
|
| |||||||
| Bodily Pain | 75.45 | 77.85 | 78.34 | 72.08 | 78.11 | 86.00 | p = 0.60 |
|
| |||||||
| General Health | 58.52 | 59.96 | 61.97 | 63.96 | 67.15 | 69.25 | p = 0.54 |
|
| |||||||
| Vitality | 44.31 | 47.20 | 49.46 | 50.34 | 54.51 | 66.25 | p = 0.36 |
|
| |||||||
| Social Functioning | 62.50 | 67.28 | 69.43 | 78.23 | 76.39 | 84.38 | p = 0.03* |
|
| |||||||
| Role-Emotional | 50.57 | 60.42 | 60.36 | 60.22 | 73.08 | 75.00 | p = 0.50 |
|
| |||||||
| Mental Health | 58.17* | 65.16 | 66.22 | 73.95* | 72.22 | 76.75 | p = 0.002* |
*
Significance between treatment groups at p<0.05